Clinical Trials Directory

Trials / Sponsors / Walvax Biotechnology Co., Ltd.

Walvax Biotechnology Co., Ltd.

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Phase 3 Study to Evaluate the Immunogenicity and Safety of Walvax's PCV13-TT as Compared to Pfizer's PCV13
Pneumococcal Disease, Invasive
Phase 32023-11-23
UnknownA Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-
COVID-19
Phase 12022-12-01
UnknownA Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-
COVID-19
Phase 12022-07-01
UnknownA Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-1
COVID-19, SARS-CoV-2
Phase 32021-07-22
CompletedA Study to Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2
Neisseria Meningitides Meningitis
Phase 42020-12-23
CompletedSafety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.
Meningococcal Infections
Phase 12018-07-17
CompletedImmunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months
Diseases Caused by Streptococcus Pneumoniae Serotypes
Phase 32016-04-08
CompletedSafety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Child
Pneumococcal Infectious Diseases
Phase 32012-09-01